bioRxivImmunology
Induction of the BIM Short Splice Variant Sensitizes Proliferating NK Cells to IL-15 Withdrawal
B. Jacobs, A. Pfefferle, D. Clement, J. P. Goodridge, M. L. Saetersmoen, S. Lorenz, M. T. Wiiger, K.-J. Malmberg
Abstract
Adoptive transfer of allogeneic NK cells holds great promise for cancer immunotherapy. There is a variety of protocols to expand NK cells in vitro, most of which are based on stimulation with cytokines alone or in combination with feeder cells. Although IL-15 is essential for NK cell homeostasis in vivo, it is commonly used at supra-physiological levels to induce NK cell proliferation in vitro. As a result, adoptive transfer of such IL-15 addicted NK cells is associated with cellular stress due to sudden cytokine withdrawal. Here, we describe a dose-dependent addiction to IL-15 during in vitro expansion, leading to caspase-3 activation and profound cell death upon IL-15 withdrawal. NK cell addiction to IL-15 was tightly linked to the BCL-2/BIM ratio, which rapidly dropped during IL-15 withdrawal. Furthermore, we observed a proliferation-dependent induction of BIM short (BIM S), a highly pro-apoptotic splice variant of BIM, in IL-15 activated NK cells. These findings shed new light on the molecular mechanisms involved in NK cell apoptosis following cytokine withdrawal and may guide future NK cell priming strategies in a cell therapy setting.
- organism: human
- assay: flow cytometry
- research focus: cell signaling & trafficking
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Long-term cytotoxic NK cells with broad anti-tumour capacity proliferate selectively, without exhaustion, after BCG priming and extremely low doses of cytokines
M.-J. Felgueres, G. Esteso, … M. Vales-Gomez·bioRxiv·Jun 7, 2023
- Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells
Anders W. Matson, Robert Hullsiek, … Bruce K. Walcheck·Journal for ImmunoTherapy of CancerPeer-reviewed·Jul 1, 2024
- Advancing Adoptive Cell Therapy: Optimized Expansion of Adaptive NK Cells for Solid Tumors
Nerea Martín Almazán, Sara Roman, … Dhifaf Sarhan·bioRxiv·Oct 2, 2024
- Myc controls IL-15-driven expansion and translational machinery of NK cells
H. J. Khameneh, N. Fonta, … G. Guarda·bioRxiv·Dec 20, 2022
- Induction of expansion of ex vivo NK cells using a new feeder cell built in Brazil. An extended flow cytometry evaluation of K562.mbIL21.4BBL
C. M. Watanabe, C. Ishihama Suzuki, … N. Hamerschlak·bioRxiv·Feb 23, 2024
- Impact of IL-21 on Natural Killer cell proliferation and Function - a mathematical and functional assessment